Welcome to the investors section of Adocia  

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.


Latest Press Releases
2018/06/08Number of shares and voting rights of ADOCIA as of May, 31 2018
Read more
2018/05/07Number of shares and voting rights of ADOCIA as of April, 30 2018
Read more

All Press releases

Next events

22-26 June, 2018 American Diabetes Association (ADA), 78th scientific sessions, Orlando, USA - The world's largest, most prominent meeting on diabetes ! The Scientific Sessions offers researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care.
See event

All events